文献速递糖尿病性腺与生殖内分泌

囊胚移植:体外受精女性妊娠期糖尿病的风险因素

Blastocyst Transfer: A Risk Factor for Gestational Diabetes Mellitus in Women Undergoing In Vitro Fertilization.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

这项前瞻性观察研究纳入1579例首次新鲜胚胎或囊胚移植后妊娠并活产的女性,比较第3天卵裂期胚胎移植与第5天囊胚移植后妊娠期糖尿病(GDM)的发生风险。结果显示囊胚移植组GDM发生率显著高于第3天胚胎移植组(21.15% vs 14.85%,P=0.009),校正混杂因素后囊胚移植仍是独立的GDM风险因素(P=0.009,Exp(B):1.56,95%CI:1.12-2.18)。

要点

  • 囊胚移植组GDM发生率21.15%,高于第3天胚胎移植组的14.85%。
  • 囊胚移植是独立的GDM风险因素(Exp(B):1.56,95%CI:1.12-2.18)。
  • 年龄、BMI、基线雌二醇、HDL及hCG日孕酮在两移植组间无差异。

核心结论

  • 体外受精/卵胞浆内单精子注射后囊胚移植增加妊娠期糖尿病发生风险。

研究设计与样本

  • 前瞻性观察研究,纳入首次新鲜胚胎或囊胚移植后妊娠的女性,共1579例妊娠并活产。
  • 1300例仅接受第3天胚胎移植,279例至少接受1个囊胚移植。

主要发现

  • 1579例女性中252例发生GDM。
  • 囊胚移植组GDM发生率显著高于第3天胚胎移植组(21.15% vs 14.85%;P=0.009)。
  • 校正混杂因素后,囊胚移植为独立的操作相关GDM风险因素(P=0.009,Exp(B):1.56,95%CI:1.12-2.18)。
  • 年龄、BMI、基线雌二醇、基线高密度脂蛋白及hCG注射日孕酮在两移植组间无差异。
  • 获卵数及卵子质量在第3天胚胎移植组与囊胚移植组间无差异。

临床怎么用

  • 对接受囊胚移植的妊娠女性应加强GDM筛查与孕期代谢监测。
  • 咨询时可告知囊胚移植与GDM风险升高相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of developing gestational diabetes mellitus (GDM) is higher in women undergoing assisted reproductive treatment than in women conceiving spontaneously. OBJECTIVES: To determine whether the GDM risk after day-3 embryo transfer differs from the GDM risk after day-5 blastocyst transfer. METHODS: Prospective observational study in women becoming pregnant after first fresh embryo or blastocyst transfer. RESULTS: A total of 1579 women got pregnant and had live birth; 1300 women got day-3 embryo transfer only, whereas 279 women received at least 1 blastocyst. Of 1579 women, 252 developed GDM. Age, body mass index, baseline estradiol, baseline high-density lipoprotein, and progesterone on the day of human chorionic gonadotropin injection were not different in women receiving day-3 embryos only vs women receiving at least 1 blastocyst. The number and quality of retrieved oocytes were not different in women receiving day-3 embryo transfer from those receiving blastocysts. Our study confirmed already established GDM risk factors such as age and body mass index, baseline estradiol, and high-density lipoprotein, as well as progesterone after ovarian stimulation. We furthermore demonstrate that the GDM incidence in women receiving day-5 blastocyst transfer was significantly higher than those who received day-3 embryo transfer (21.15% vs 14.85%; P = 0.009). Considering confounding factors, we likewise saw that blastocyst transfer was an independent procedure-related GDM risk factor [P = 0.009, Exp (B): 1.56, 95% CI: 1.12-2.18]. CONCLUSION: Blastocyst transfer after in vitro fertilization/intracytoplasmic sperm injection increases the risk of developing GDM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chen H, Li J, Cai S, et al. Blastocyst Transfer: A Risk Factor for Gestational Diabetes Mellitus in Women Undergoing In Vitro Fertilization. J Clin Endocrinol Metab. 2022. PMID: 34415990. doi:10.1210/clinem/dgab594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。